Article | April 22, 2022

From Good To Great: Innovative Biopharmaceutical Manufacturing Is Key

By Dr. Latika Bhonsle-Deeng, Senior Manager Corporate Communication, Rentschler Biopharma SE


The recent past has strongly demonstrated the true potential of biopharmaceuticals, and the coming years promise to further strengthen their global position and reputation. This growth, for the short- and long-term, can best be sustained by advancing innovations in process development and manufacturing.

In pursuit of better treatments to alleviate suffering and improve human lives, biopharmaceuticals have proved to be a game-changer. Fueled by the transition from small molecules to formats with increasing complexity- be it proteins or nucleic acids, and an increase in druggable targets, these biopharmaceuticals are here to stay.

Today, biopharmaceuticals and the manufacturing processes that make them possible, contribute immensely to treating and improving the lives of innumerable patients across the globe. The recent past has shown us how advanced manufacturing can be leveraged to produce new technology like mRNA within cGMP requirements and demanding timelines. Join us in taking a closer look at what this means for scalability and continuous manufacturing.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma